SLE to collaborate with University of Tasmania to license breakthrough technology
SLE Ltd (UK) and the University of Tasmania are to collaborate on the commercialisation of lifesaving technology aimed at newborn infants requiring artificial respiration and oxygen.
The technology has been developed over the last nine years by a team of scientists led by Professor Peter Dargaville of the Tasmanian Health Service and Dr Tim Gale of the School of Engineering and ICT at the University of Tasmania. It uses a closed-loop control algorithm to maintain an optimised oxygen concentration in the blood circulation of infants and can be integrated to devices that provide respiratory support.
Past multi-centre studies have shown that vulnerable infants are very susceptible to changes in the oxygen in their circulation, and the maintenance of this blood oxygen in a narrow but critical band may reduce mortality, retinal damage and other long-term effects. The closed loop technology keeps the infant within this tight range for an extended period of time without the intervention of clinical staff.
Trials of the technology demonstrated that use of the closed loop control improved the time an infant spent within this target range by 25%.
See our Supplier Guide: